SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001408617-08-000035
Filing Date
2008-06-05
Accepted
2008-06-05 15:20:44
Documents
1
Period of Report
2008-05-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3992
  Complete submission text file 0001408617-08-000035.txt   5814
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address
Business Address 420 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108 8015834939
KUHLA DONALD E (Reporting) CIK: 0001013421 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-23272 | Film No.: 08882877